...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: 8 weeks into ZEN-3694 trial today
Reply New Message
Back To Forum List View

Today is 8 weeks since start of dosing of first patient on June 15. From what I understand of the 3+3 design, dosing can increase to the next dose level every 4 weeks. So we should be into the 3rd dosing level soon.

Best regards,

BearDownAZ

4 Recommendations
Re: 8 weeks into ZEN-3694 trial today
3
fouremm
Aug 10, 2016 10:44PM
Icon president Re: 8 weeks into ZEN-3694 trial today
3
BearDownAZ
Aug 10, 2016 10:52PM
Icon president Re: 8 weeks into ZEN-3694 trial today
4
SanFrancisco99
Aug 11, 2016 04:37PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply